par Sculier, Jean-Paul ;Lafitte, Jean-Jacques;Lecomte, J.;Alexopoulos, Constantinos;Van Cutsem, O;Giner, Vicente;Efremidis, Anna;Berchier, M.C.;Collon, Thierry;Meert, Anne-Pascale ;Scherpereel, Arnaud;Ninane, Vincent ;Paesmans, Marianne ;Berghmans, Thierry
Référence Annals of oncology, 18, 6, page (1037-1042)
Publication Publié, 2007-06
Référence Annals of oncology, 18, 6, page (1037-1042)
Publication Publié, 2007-06
Article révisé par les pairs
Résumé : | The purpose of this study is to determine whether in advanced non-small-cell lung cancer (NSCLC), the sequential administration of cisplatin-based chemotherapy and paclitaxel (Taxol) is superior to a cisplatin-based chemotherapy, followed by paclitaxel as salvage treatment. |